ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

In Brief: New NIH Grant Program Offers Up To $1 Million a Year For Centers At Minority Institutions

January 25, 1985

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006